Table of Content

1 Report Overview
1.1 Biologic Drugs Definition
1.2 Market by Type
1.2.1 Global Biologic Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Humira
1.2.3 Remicade
1.2.4 Rituxan
1.2.5 Enbrel
1.2.6 Lantus
1.2.7 Avastin
1.2.8 Herceptin
1.2.9 Others
1.3 Market Segment by Application
1.3.1 Global Biologic Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Diabetes
1.3.3 Inflammation
1.3.4 Auto-Immune Diseases
1.3.5 Blood Diseases
1.3.6 Cardiovascular Diseases
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Biologic Drugs Sales
2.1 Global Biologic Drugs Revenue Estimates and Forecasts 2018-2034
2.2 Global Biologic Drugs Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Biologic Drugs Revenue by Region
2.3.1 Global Biologic Drugs Revenue by Region (2018-2024)
2.3.2 Global Biologic Drugs Revenue by Region (2024-2034)
2.4 Global Biologic Drugs Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Biologic Drugs Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Biologic Drugs Sales Quantity by Region
2.6.1 Global Biologic Drugs Sales Quantity by Region (2018-2024)
2.6.2 Global Biologic Drugs Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Biologic Drugs Sales Quantity by Manufacturers
3.1.1 Global Biologic Drugs Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Biologic Drugs Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Biologic Drugs Sales in 2022
3.2 Global Biologic Drugs Revenue by Manufacturers
3.2.1 Global Biologic Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Biologic Drugs Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Biologic Drugs Revenue in 2022
3.3 Global Biologic Drugs Sales Price by Manufacturers
3.4 Global Key Players of Biologic Drugs, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Biologic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Biologic Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Biologic Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Biologic Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Biologic Drugs Sales Quantity by Type
4.1.1 Global Biologic Drugs Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Biologic Drugs Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Biologic Drugs Sales Quantity Market Share by Type (2018-2034)
4.2 Global Biologic Drugs Revenue by Type
4.2.1 Global Biologic Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Biologic Drugs Forecasted Revenue by Type (2024-2034)
4.2.3 Global Biologic Drugs Revenue Market Share by Type (2018-2034)
4.3 Global Biologic Drugs Price by Type
4.3.1 Global Biologic Drugs Price by Type (2018-2024)
4.3.2 Global Biologic Drugs Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Biologic Drugs Sales Quantity by Application
5.1.1 Global Biologic Drugs Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Biologic Drugs Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Biologic Drugs Sales Quantity Market Share by Application (2018-2034)
5.2 Global Biologic Drugs Revenue by Application
5.2.1 Global Biologic Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Biologic Drugs Forecasted Revenue by Application (2024-2034)
5.2.3 Global Biologic Drugs Revenue Market Share by Application (2018-2034)
5.3 Global Biologic Drugs Price by Application
5.3.1 Global Biologic Drugs Price by Application (2018-2024)
5.3.2 Global Biologic Drugs Price Forecast by Application (2024-2034)
6 North America
6.1 North America Biologic Drugs Sales by Company
6.1.1 North America Biologic Drugs Revenue by Company (2018-2024)
6.1.2 North America Biologic Drugs Sales Quantity by Company (2018-2024)
6.2 North America Biologic Drugs Market Size by Type
6.2.1 North America Biologic Drugs Sales Quantity by Type (2018-2034)
6.2.2 North America Biologic Drugs Revenue by Type (2018-2034)
6.3 North America Biologic Drugs Market Size by Application
6.3.1 North America Biologic Drugs Sales Quantity by Application (2018-2034)
6.3.2 North America Biologic Drugs Revenue by Application (2018-2034)
6.4 North America Biologic Drugs Market Size by Country
6.4.1 North America Biologic Drugs Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Biologic Drugs Revenue by Country (2018-2034)
6.4.3 North America Biologic Drugs Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Biologic Drugs Sales by Company
7.1.1 Europe Biologic Drugs Sales Quantity by Company (2018-2024)
7.1.2 Europe Biologic Drugs Revenue by Company (2018-2024)
7.2 Europe Biologic Drugs Market Size by Type
7.2.1 Europe Biologic Drugs Sales Quantity by Type (2018-2034)
7.2.2 Europe Biologic Drugs Revenue by Type (2018-2034)
7.3 Europe Biologic Drugs Market Size by Application
7.3.1 Europe Biologic Drugs Sales Quantity by Application (2018-2034)
7.3.2 Europe Biologic Drugs Revenue by Application (2018-2034)
7.4 Europe Biologic Drugs Market Size by Country
7.4.1 Europe Biologic Drugs Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Biologic Drugs Revenue by Country (2018-2034)
7.4.3 Europe Biologic Drugs Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Biologic Drugs Sales by Company
8.1.1 China Biologic Drugs Sales Quantity by Company (2018-2024)
8.1.2 China Biologic Drugs Revenue by Company (2018-2024)
8.2 China Biologic Drugs Market Size by Type
8.2.1 China Biologic Drugs Sales Quantity by Type (2018-2034)
8.2.2 China Biologic Drugs Revenue by Type (2018-2034)
8.3 China Biologic Drugs Market Size by Application
8.3.1 China Biologic Drugs Sales Quantity by Application (2018-2034)
8.3.2 China Biologic Drugs Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Biologic Drugs Sales by Company
9.1.1 APAC Biologic Drugs Sales Quantity by Company (2018-2024)
9.1.2 APAC Biologic Drugs Revenue by Company (2018-2024)
9.2 APAC Biologic Drugs Market Size by Type
9.2.1 APAC Biologic Drugs Sales Quantity by Type (2018-2034)
9.2.2 APAC Biologic Drugs Revenue by Type (2018-2034)
9.3 APAC Biologic Drugs Market Size by Application
9.3.1 APAC Biologic Drugs Sales Quantity by Application (2018-2034)
9.3.2 APAC Biologic Drugs Revenue by Application (2018-2034)
9.4 APAC Biologic Drugs Market Size by Region
9.4.1 APAC Biologic Drugs Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Biologic Drugs Revenue by Region (2018-2034)
9.4.3 APAC Biologic Drugs Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Biologic Drugs Sales by Company
10.1.1 Middle East, Africa and Latin America Biologic Drugs Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Biologic Drugs Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Biologic Drugs Market Size by Type
10.2.1 Middle East, Africa and Latin America Biologic Drugs Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Biologic Drugs Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Biologic Drugs Market Size by Application
10.3.1 Middle East, Africa and Latin America Biologic Drugs Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Biologic Drugs Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Biologic Drugs Market Size by Country
10.4.1 Middle East, Africa and Latin America Biologic Drugs Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Biologic Drugs Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Biologic Drugs Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Overview
11.1.3 Roche Biologic Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Roche Biologic Drugs Products and Services
11.1.5 Roche Biologic Drugs SWOT Analysis
11.1.6 Roche Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Information
11.2.2 Abbott Laboratories Overview
11.2.3 Abbott Laboratories Biologic Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Abbott Laboratories Biologic Drugs Products and Services
11.2.5 Abbott Laboratories Biologic Drugs SWOT Analysis
11.2.6 Abbott Laboratories Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Biologic Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Johnson & Johnson Biologic Drugs Products and Services
11.3.5 Johnson & Johnson Biologic Drugs SWOT Analysis
11.3.6 Johnson & Johnson Recent Developments
11.4 Merck & Co.
11.4.1 Merck & Co. Company Information
11.4.2 Merck & Co. Overview
11.4.3 Merck & Co. Biologic Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Merck & Co. Biologic Drugs Products and Services
11.4.5 Merck & Co. Biologic Drugs SWOT Analysis
11.4.6 Merck & Co. Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Biologic Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Pfizer Biologic Drugs Products and Services
11.5.5 Pfizer Biologic Drugs SWOT Analysis
11.5.6 Pfizer Recent Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Overview
11.6.3 Amgen Biologic Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Amgen Biologic Drugs Products and Services
11.6.5 Amgen Biologic Drugs SWOT Analysis
11.6.6 Amgen Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Biologic Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Sanofi Biologic Drugs Products and Services
11.7.5 Sanofi Biologic Drugs SWOT Analysis
11.7.6 Sanofi Recent Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Overview
11.8.3 Novartis Biologic Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Novartis Biologic Drugs Products and Services
11.8.5 Novartis Biologic Drugs SWOT Analysis
11.8.6 Novartis Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Company Information
11.9.2 Eli Lilly Overview
11.9.3 Eli Lilly Biologic Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Eli Lilly Biologic Drugs Products and Services
11.9.5 Eli Lilly Biologic Drugs SWOT Analysis
11.9.6 Eli Lilly Recent Developments
11.10 Amgen
11.10.1 Amgen Company Information
11.10.2 Amgen Overview
11.10.3 Amgen Biologic Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Amgen Biologic Drugs Products and Services
11.10.5 Amgen Biologic Drugs SWOT Analysis
11.10.6 Amgen Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Biologic Drugs Value Chain Analysis
12.2 Biologic Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biologic Drugs Production Mode & Process
12.4 Biologic Drugs Sales and Marketing
12.4.1 Biologic Drugs Sales Channels
12.4.2 Biologic Drugs Distributors
12.5 Biologic Drugs Customers
13 Market Dynamics
13.1 Biologic Drugs Industry Trends
13.2 Biologic Drugs Market Drivers
13.3 Biologic Drugs Market Challenges
13.4 Biologic Drugs Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Biologic Drugs Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Humira
Table 3. Major Manufacturers of Remicade
Table 4. Major Manufacturers of Rituxan
Table 5. Major Manufacturers of Enbrel
Table 6. Major Manufacturers of Lantus
Table 7. Major Manufacturers of Avastin
Table 8. Major Manufacturers of Herceptin
Table 9. Major Manufacturers of Others
Table 10. Global Biologic Drugs Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 11. Global Biologic Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 12. Global Biologic Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 13. Global Biologic Drugs Revenue Market Share by Region (2018-2024)
Table 14. Global Biologic Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 15. Global Biologic Drugs Revenue Market Share by Region (2024-2034)
Table 16. Global Biologic Drugs Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 17. Global Biologic Drugs Sales by Region (2018-2024) & (K Units)
Table 18. Global Biologic Drugs Sales Market Share by Region (2018-2024)
Table 19. Global Biologic Drugs Sales by Region (2024-2034) & (K Units)
Table 20. Global Biologic Drugs Sales Market Share by Region (2024-2034)
Table 21. Global Biologic Drugs Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 22. Global Biologic Drugs Sales Quantity Share by Manufacturers (2018-2024)
Table 23. Global Biologic Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 24. Global Biologic Drugs Revenue Share by Manufacturers (2018-2024)
Table 25. Global Biologic Drugs Price by Manufacturers 2018-2024 (USD/Unit)
Table 26. Global Key Players of Biologic Drugs, Industry Ranking, 2021 VS 2022
Table 27. Global Biologic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Biologic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Drugs as of 2022)
Table 29. Global Key Manufacturers of Biologic Drugs, Manufacturing Base Distribution and Headquarters
Table 30. Global Key Manufacturers of Biologic Drugs, Product Offered and Application
Table 31. Global Key Manufacturers of Biologic Drugs, Date of Enter into This Industry
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Biologic Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 34. Global Biologic Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 35. Global Biologic Drugs Sales Quantity Share by Type (2018-2024)
Table 36. Global Biologic Drugs Sales Quantity Share by Type (2024-2034)
Table 37. Global Biologic Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 38. Global Biologic Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 39. Global Biologic Drugs Revenue Share by Type (2018-2024)
Table 40. Global Biologic Drugs Revenue Share by Type (2024-2034)
Table 41. Biologic Drugs Price by Type (2018-2024) & (USD/Unit)
Table 42. Global Biologic Drugs Price Forecast by Type (2024-2034) & (USD/Unit)
Table 43. Global Biologic Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 44. Global Biologic Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 45. Global Biologic Drugs Sales Quantity Share by Application (2018-2024)
Table 46. Global Biologic Drugs Sales Quantity Share by Application (2024-2034)
Table 47. Global Biologic Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 48. Global Biologic Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 49. Global Biologic Drugs Revenue Share by Application (2018-2024)
Table 50. Global Biologic Drugs Revenue Share by Application (2024-2034)
Table 51. Biologic Drugs Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Biologic Drugs Price Forecast by Application (2024-2034) & (USD/Unit)
Table 53. North America Biologic Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 54. North America Biologic Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 55. North America Biologic Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 56. North America Biologic Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 57. North America Biologic Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 58. North America Biologic Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 59. North America Biologic Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 60. North America Biologic Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 61. North America Biologic Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 62. North America Biologic Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 63. North America Biologic Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 64. North America Biologic Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 65. North America Biologic Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 66. North America Biologic Drugs Sales Quantity by Country (2018-2024) & (K Units)
Table 67. North America Biologic Drugs Sales Quantity by Country (2024-2034) & (K Units)
Table 68. Europe Biologic Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 69. Europe Biologic Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 70. Europe Biologic Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 71. Europe Biologic Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 72. Europe Biologic Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 73. Europe Biologic Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 74. Europe Biologic Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 75. Europe Biologic Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 76. Europe Biologic Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 77. Europe Biologic Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 78. Europe Biologic Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 79. Europe Biologic Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 80. Europe Biologic Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 81. Europe Biologic Drugs Sales Quantity by Country (2018-2024) & (K Units)
Table 82. Europe Biologic Drugs Sales Quantity by Country (2024-2034) & (K Units)
Table 83. China Biologic Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 84. China Biologic Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 85. China Biologic Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 86. China Biologic Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 87. China Biologic Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 88. China Biologic Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 89. China Biologic Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 90. China Biologic Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 91. China Biologic Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 92. China Biologic Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 93. APAC Biologic Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 94. APAC Biologic Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 95. APAC Biologic Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 96. APAC Biologic Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 97. APAC Biologic Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 98. APAC Biologic Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 99. APAC Biologic Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 100. APAC Biologic Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 101. APAC Biologic Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 102. APAC Biologic Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 103. APAC Biologic Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 104. APAC Biologic Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 105. APAC Biologic Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 106. APAC Biologic Drugs Sales Quantity by Region (2018-2024) & (K Units)
Table 107. APAC Biologic Drugs Sales Quantity by Region (2024-2034) & (K Units)
Table 108. Middle East, Africa and Latin America Biologic Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Biologic Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 110. Middle East, Africa and Latin America Biologic Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 111. Middle East, Africa and Latin America Biologic Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 112. Middle East, Africa and Latin America Biologic Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Biologic Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Biologic Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 115. Middle East, Africa and Latin America Biologic Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 116. Middle East, Africa and Latin America Biologic Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 117. Middle East, Africa and Latin America Biologic Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Biologic Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 119. Middle East, Africa and Latin America Biologic Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 120. Middle East, Africa and Latin America Biologic Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 121. Middle East, Africa and Latin America Biologic Drugs Sales Quantity by Country (2018-2024) & (K Units)
Table 122. Middle East, Africa and Latin America Biologic Drugs Sales Quantity by Country (2024-2034) & (K Units)
Table 123. Roche Company Information
Table 124. Roche Description and Overview
Table 125. Roche Biologic Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 126. Roche Biologic Drugs Product and Services
Table 127. Roche Biologic Drugs SWOT Analysis
Table 128. Roche Recent Developments
Table 129. Abbott Laboratories Company Information
Table 130. Abbott Laboratories Description and Overview
Table 131. Abbott Laboratories Biologic Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 132. Abbott Laboratories Biologic Drugs Product and Services
Table 133. Abbott Laboratories Biologic Drugs SWOT Analysis
Table 134. Abbott Laboratories Recent Developments
Table 135. Johnson & Johnson Company Information
Table 136. Johnson & Johnson Description and Overview
Table 137. Johnson & Johnson Biologic Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 138. Johnson & Johnson Biologic Drugs Product and Services
Table 139. Johnson & Johnson Biologic Drugs SWOT Analysis
Table 140. Johnson & Johnson Recent Developments
Table 141. Merck & Co. Company Information
Table 142. Merck & Co. Description and Overview
Table 143. Merck & Co. Biologic Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 144. Merck & Co. Biologic Drugs Product and Services
Table 145. Merck & Co. Biologic Drugs SWOT Analysis
Table 146. Merck & Co. Recent Developments
Table 147. Pfizer Company Information
Table 148. Pfizer Description and Overview
Table 149. Pfizer Biologic Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 150. Pfizer Biologic Drugs Product and Services
Table 151. Pfizer Biologic Drugs SWOT Analysis
Table 152. Pfizer Recent Developments
Table 153. Amgen Company Information
Table 154. Amgen Description and Overview
Table 155. Amgen Biologic Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 156. Amgen Biologic Drugs Product and Services
Table 157. Amgen Biologic Drugs SWOT Analysis
Table 158. Amgen Recent Developments
Table 159. Sanofi Company Information
Table 160. Sanofi Description and Overview
Table 161. Sanofi Biologic Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 162. Sanofi Biologic Drugs Product and Services
Table 163. Sanofi Biologic Drugs SWOT Analysis
Table 164. Sanofi Recent Developments
Table 165. Novartis Company Information
Table 166. Novartis Description and Overview
Table 167. Novartis Biologic Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 168. Novartis Biologic Drugs Product and Services
Table 169. Novartis Biologic Drugs SWOT Analysis
Table 170. Novartis Recent Developments
Table 171. Eli Lilly Company Information
Table 172. Eli Lilly Description and Overview
Table 173. Eli Lilly Biologic Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 174. Eli Lilly Biologic Drugs Product and Services
Table 175. Eli Lilly Biologic Drugs SWOT Analysis
Table 176. Eli Lilly Recent Developments
Table 177. Amgen Company Information
Table 178. Amgen Description and Overview
Table 179. Amgen Biologic Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 180. Amgen Biologic Drugs Product and Services
Table 181. Amgen Biologic Drugs SWOT Analysis
Table 182. Amgen Recent Developments
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Biologic Drugs Distributors List
Table 186. Biologic Drugs Customers List
Table 187. Biologic Drugs Market Trends
Table 188. Biologic Drugs Market Drivers
Table 189. Biologic Drugs Market Challenges
Table 190. Biologic Drugs Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologic Drugs Product Picture
Figure 2. Global Biologic Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Biologic Drugs Market Share by Type in 2022 & 2034
Figure 4. Humira Product Picture
Figure 5. Remicade Product Picture
Figure 6. Rituxan Product Picture
Figure 7. Enbrel Product Picture
Figure 8. Lantus Product Picture
Figure 9. Avastin Product Picture
Figure 10. Herceptin Product Picture
Figure 11. Others Product Picture
Figure 12. Global Biologic Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 13. Global Biologic Drugs Market Share by Application in 2022 & 2034
Figure 14. Diabetes
Figure 15. Inflammation
Figure 16. Auto-Immune Diseases
Figure 17. Blood Diseases
Figure 18. Cardiovascular Diseases
Figure 19. Others
Figure 20. Biologic Drugs Report Years Considered
Figure 21. Global Biologic Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 22. Global Biologic Drugs Revenue 2018-2034 (US$ Million)
Figure 23. Global Biologic Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 24. Global Biologic Drugs Sales Quantity 2018-2034 (K Units)
Figure 25. Global Biologic Drugs Sales Quantity Market Share by Region (2018-2024)
Figure 26. Global Biologic Drugs Sales Quantity Market Share by Region (2024-2034)
Figure 27. North America Biologic Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. North America Biologic Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Europe Biologic Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 30. Europe Biologic Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 31. China Biologic Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 32. China Biologic Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 33. APAC Biologic Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 34. APAC Biologic Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 35. Middle East, Africa and Latin America Biologic Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 36. Middle East, Africa and Latin America Biologic Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 37. The Top 10 and Top 5 Players Market Share by Biologic Drugs Sales Quantity in 2022
Figure 38. The Top 10 and Top 5 Players Market Share by Biologic Drugs Revenue in 2022
Figure 39. Biologic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 40. Global Biologic Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 41. Global Biologic Drugs Revenue Market Share by Type (2018-2034)
Figure 42. Global Biologic Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 43. Global Biologic Drugs Revenue Market Share by Application (2018-2034)
Figure 44. North America Biologic Drugs Revenue Market Share by Company in 2022
Figure 45. North America Biologic Drugs Sales Quantity Market Share by Company in 2022
Figure 46. North America Biologic Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 47. North America Biologic Drugs Revenue Market Share by Type (2018-2034)
Figure 48. North America Biologic Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 49. North America Biologic Drugs Revenue Market Share by Application (2018-2034)
Figure 50. North America Biologic Drugs Revenue Share by Country (2018-2034)
Figure 51. North America Biologic Drugs Sales Quantity Share by Country (2018-2034)
Figure 52. U.S. Biologic Drugs Revenue (2018-2034) & (US$ Million)
Figure 53. Canada Biologic Drugs Revenue (2018-2034) & (US$ Million)
Figure 54. Europe Biologic Drugs Sales Quantity Market Share by Company in 2022
Figure 55. Europe Biologic Drugs Revenue Market Share by Company in 2022
Figure 56. Europe Biologic Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 57. Europe Biologic Drugs Revenue Market Share by Type (2018-2034)
Figure 58. Europe Biologic Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 59. Europe Biologic Drugs Revenue Market Share by Application (2018-2034)
Figure 60. Europe Biologic Drugs Revenue Share by Country (2018-2034)
Figure 61. Europe Biologic Drugs Sales Quantity Share by Country (2018-2034)
Figure 62. Germany Biologic Drugs Revenue (2018-2034) & (US$ Million)
Figure 63. France Biologic Drugs Revenue (2018-2034) & (US$ Million)
Figure 64. U.K. Biologic Drugs Revenue (2018-2034) & (US$ Million)
Figure 65. Italy Biologic Drugs Revenue (2018-2034) & (US$ Million)
Figure 66. Russia Biologic Drugs Revenue (2018-2034) & (US$ Million)
Figure 67. China Biologic Drugs Sales Quantity Market Share by Company in 2022
Figure 68. China Biologic Drugs Revenue Market Share by Company in 2022
Figure 69. China Biologic Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 70. China Biologic Drugs Revenue Market Share by Type (2018-2034)
Figure 71. China Biologic Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 72. China Biologic Drugs Revenue Market Share by Application (2018-2034)
Figure 73. APAC Biologic Drugs Sales Quantity Market Share by Company in 2022
Figure 74. APAC Biologic Drugs Revenue Market Share by Company in 2022
Figure 75. APAC Biologic Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 76. APAC Biologic Drugs Revenue Market Share by Type (2018-2034)
Figure 77. APAC Biologic Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 78. APAC Biologic Drugs Revenue Market Share by Application (2018-2034)
Figure 79. APAC Biologic Drugs Revenue Share by Region (2018-2034)
Figure 80. APAC Biologic Drugs Sales Quantity Share by Region (2018-2034)
Figure 81. Japan Biologic Drugs Revenue (2018-2034) & (US$ Million)
Figure 82. South Korea Biologic Drugs Revenue (2018-2034) & (US$ Million)
Figure 83. China Taiwan Biologic Drugs Revenue (2018-2034) & (US$ Million)
Figure 84. Southeast Asia Biologic Drugs Revenue (2018-2034) & (US$ Million)
Figure 85. India Biologic Drugs Revenue (2018-2034) & (US$ Million)
Figure 86. Middle East, Africa and Latin America Biologic Drugs Sales Quantity Market Share by Company in 2022
Figure 87. Middle East, Africa and Latin America Biologic Drugs Revenue Market Share by Company in 2022
Figure 88. Middle East, Africa and Latin America Biologic Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 89. Middle East, Africa and Latin America Biologic Drugs Revenue Market Share by Type (2018-2034)
Figure 90. Middle East, Africa and Latin America Biologic Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 91. Middle East, Africa and Latin America Biologic Drugs Revenue Market Share by Application (2018-2034)
Figure 92. Middle East, Africa and Latin America Biologic Drugs Sales Quantity Share by Country (2018-2034)
Figure 93. Middle East, Africa and Latin America Biologic Drugs Revenue Share by Country (2018-2034)
Figure 94. Brazil Biologic Drugs Revenue (2018-2034) & (US$ Million)
Figure 95. Mexico Biologic Drugs Revenue (2018-2034) & (US$ Million)
Figure 96. Turkey Biologic Drugs Revenue (2018-2034) & (US$ Million)
Figure 97. Israel Biologic Drugs Revenue (2018-2034) & (US$ Million)
Figure 98. GCC Countries Biologic Drugs Revenue (2018-2034) & (US$ Million)
Figure 99. Biologic Drugs Value Chain
Figure 100. Biologic Drugs Production Process
Figure 101. Channels of Distribution (Direct Vs Distribution)
Figure 102. Distributors Profiles
Figure 103. Bottom-up and Top-down Approaches for This Report
Figure 104. Data Triangulation
Figure 105. Key Executives Interviewed